WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

WhiteOak Capital Pharma and Heathcare Fund: AUM ₹133 Cr, expense ratio 1.28%, 1Y return +18.24%. Track returns, risk and NAV history.

Fund Metrics & Risk Analysis

Fund House (AMC)WhiteOak Capital Mutual Fund
CategoryEquity Scheme - Sectoral/ Thematic
Scheme Code152349
ISININF03VN01886
AUM₹133 Cr
Expense Ratio1.28%
Launch Date16-01-2024 (2.9 yrs)
1-Year Return+18.24%
Alpha (vs Nifty 50)+23.15%
Standard Deviation13.80%
Sortino Ratio1.30
Exit LoadEntry Load: Nil Exit Load: Nil

Investment Tools

Frequently Asked Questions

What is the latest NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

You can check the live AMFI NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth (Scheme Code: 152349) on this page or in our Live Data scanner.

What is the expense ratio of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

The expense ratio of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 1.28% per annum, deducted daily from the scheme's Net Asset Value (NAV).

What is the AUM and launch date of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth manages Assets Under Management (AUM) of approximately ₹133 Cr and was launched on 16-01-2024.

What are the historical trailing returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

Trailing annualized returns for WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 1-Year: +18.24%. Past performance is not indicative of future results.

What is the AMFI scheme code and ISIN for WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?

The AMFI scheme code for WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 152349 and its ISIN is INF03VN01886. It is managed by WhiteOak Capital Mutual Fund.

Top Peers in Equity Scheme - Sectoral/ Thematic